{"entity":{"type":"insider","cik":"0001594274","url":"/insider/0001594274","json_url":"/insider/0001594274.json","name":"Ordentlich Peter","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":8,"first":"2017-05-19","last":"2023-02-17","span_basis":"filed_date"},"name_variants":[{"name":"Ordentlich Peter","source":"filing","n_filings":8,"first_seen":"2017-05-19","last_seen":"2023-02-17"}],"transactions":[{"id":8083710,"accession":"0001562180-23-001533","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-23-001533","line_url":"/filing/0001562180-23-001533","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001594274","owner_name":"Ordentlich Peter","owner_display_name":"Ordentlich Peter","owner_url":"/insider/0001594274","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":25.8437,"price_display":"25.84","price_state":"stated","total_value":646092.5,"total_display":"646,092.50","total_whole":"646,093","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-15","filed_date":"2023-02-17","scope":"insider","n_lines":2},{"id":8331580,"accession":"0001562180-23-000950","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-000950","line_url":"/filing/0001562180-23-000950#line-2","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001594274","owner_name":"Ordentlich Peter","owner_display_name":"Ordentlich Peter","owner_url":"/insider/0001594274","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69.0,"shares_display":"69","price_per_share":28.4281,"price_display":"28.43","price_state":"stated","total_value":1961.5389,"total_display":"1,961.54","total_whole":"1,962","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-03","scope":"insider"},{"id":6951784,"accession":"0001562180-22-008017","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-22-008017","line_url":"/filing/0001562180-22-008017#line-6","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001594274","owner_name":"Ordentlich Peter","owner_display_name":"Ordentlich Peter","owner_url":"/insider/0001594274","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17200.0,"shares_display":"17,200","price_per_share":25.0544,"price_display":"25.05","price_state":"stated","total_value":430935.68,"total_display":"430,935.68","total_whole":"430,936","shares_owned_after":265.0,"shares_owned_after_display":"265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-02","scope":"insider"},{"id":6951777,"accession":"0001562180-22-008017","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-22-008017","line_url":"/filing/0001562180-22-008017","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001594274","owner_name":"Ordentlich Peter","owner_display_name":"Ordentlich Peter","owner_url":"/insider/0001594274","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7800.0,"shares_display":"7,800","price_per_share":25.0114,"price_display":"25.01","price_state":"stated","total_value":195088.92,"total_display":"195,088.92","total_whole":"195,089","shares_owned_after":265.0,"shares_owned_after_display":"265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-02","scope":"insider","n_lines":2},{"id":6900462,"accession":"0001562180-22-006334","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-22-006334","line_url":"/filing/0001562180-22-006334","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001594274","owner_name":"Ordentlich Peter","owner_display_name":"Ordentlich Peter","owner_url":"/insider/0001594274","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":25.0357,"price_display":"25.04","price_state":"stated","total_value":625892.5,"total_display":"625,892.50","total_whole":"625,893","shares_owned_after":265.0,"shares_owned_after_display":"265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-24","filed_date":"2022-08-26","scope":"insider","n_lines":2},{"id":6685714,"accession":"0001562180-22-001079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-001079","line_url":"/filing/0001562180-22-001079#line-2","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001594274","owner_name":"Ordentlich Peter","owner_display_name":"Ordentlich Peter","owner_url":"/insider/0001594274","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1412.0,"shares_display":"1,412","price_per_share":16.65,"price_display":"16.65","price_state":"stated","total_value":23509.8,"total_display":"23,509.80","total_whole":"23,510","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-01","filed_date":"2022-02-03","scope":"insider"},{"id":2270572,"accession":"0001562180-20-006920","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-20-006920","line_url":"/filing/0001562180-20-006920","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001594274","owner_name":"Ordentlich Peter","owner_display_name":"Ordentlich Peter","owner_url":"/insider/0001594274","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29972.0,"shares_display":"29,972","price_per_share":23.158993747497664,"price_display":"23.16","price_state":"stated","total_value":694121.3606,"total_display":"694,121.36","total_whole":"694,121","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-25","scope":"insider","n_lines":3},{"id":6448800,"accession":"0001562180-18-001800","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-001800","line_url":"/filing/0001562180-18-001800#line-2","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001594274","owner_name":"Ordentlich Peter","owner_display_name":"Ordentlich Peter","owner_url":"/insider/0001594274","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":112500.0,"total_display":"112,500.00","total_whole":"112,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-03","filed_date":"2018-04-03","scope":"insider"},{"id":5025378,"accession":"0001562180-17-002011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-17-002011","line_url":"/filing/0001562180-17-002011#line-2","is_derivative":false,"issuer_cik":"0001395937","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001395937","owner_cik":"0001594274","owner_name":"Ordentlich Peter","owner_display_name":"Ordentlich Peter","owner_url":"/insider/0001594274","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-17","filed_date":"2017-05-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001395937","name":"Syndax Pharmaceuticals Inc","url":"/issuer/0001395937","role":"Officer (Chief Scientific Officer)","n_filings":8,"first_seen":"2017-05-19","last_seen":"2023-02-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001594274","retrieved_at":"2026-08-25T00:08:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}